Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.74 USD | -5.31% | -10.97% | -6.66% |
05-15 | HC Wainwright Adjusts Korro Bio's Price Target to $100 From $115, Keeps Buy Rating | MT |
05-14 | Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
438M | - | - | - | - | - | |
59.34B | - | |||||
40.24B | ||||||
39.88B | ||||||
28.55B | ||||||
27.26B |
- Stock Market
- Equities
- KRRO Stock
- Charts Korro Bio, Inc.
- Sector Chart